This topic contains a solution. Click here to go to the answer

Author Question: An adult patient with diagnoses of liver cirrhosis and hepatitis C is exhibiting signs and symptoms ... (Read 42 times)

CharlieWard

  • Hero Member
  • *****
  • Posts: 578
An adult patient with diagnoses of liver cirrhosis and hepatitis C is exhibiting signs and symptoms of hypovolemic shock. How will the patient's compromised hepatic function affect the possible use of epinephrine?
 
  A) The patient will require a higher-than-normal dose.
  B) The patient's hepatic function is not a priority consideration.
  C) The patient should not receive epinephrine by a parenteral route.
  D) The patient should receive a small fraction of the normal dose.

Question 2

An 80-year-old patient has been prescribed an anticholinergic agent for treatment of Parkinson-related symptoms. What patient education should be provided?
 
  A) Avoid high environmental temperatures.
  B) Anticholinergics increase mental alertness.
  C) It is safe to take Sudafed for a cold.
  D) You may experience urinary incontinence.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

amcvicar

  • Sr. Member
  • ****
  • Posts: 341
Answer to Question 1

B
Feedback:
Liver disease is not usually considered a contraindication to administering adrenergic drugs. Dosages do not normally need to be adjusted.

Answer to Question 2

A
Feedback:
Anticholinergic drugs decrease sweating and may cause heat stroke. The patient should be instructed to avoid high environmental temperatures. Anticholinergic agents will decrease mental alertness. Sudafed will produce anticholinergic effects and should not be administered. Anticholinergic agents produce urinary retention, not incontinence.



CharlieWard

  • Hero Member
  • *****
  • Posts: 578
Both answers were spot on, thank you once again




 

Did you know?

The Centers for Disease Control and Prevention (CDC) was originally known as the Communicable Disease Center, which was formed to fight malaria. It was originally headquartered in Atlanta, Georgia, since the Southern states faced the worst threat from malaria.

Did you know?

According to the National Institute of Environmental Health Sciences, lung disease is the third leading killer in the United States, responsible for one in seven deaths. It is the leading cause of death among infants under the age of one year.

Did you know?

Many people have small pouches in their colons that bulge outward through weak spots. Each pouch is called a diverticulum. About 10% of Americans older than age 40 years have diverticulosis, which, when the pouches become infected or inflamed, is called diverticulitis. The main cause of diverticular disease is a low-fiber diet.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

Did you know?

Though “Krazy Glue” or “Super Glue” has the ability to seal small wounds, it is not recommended for this purpose since it contains many substances that should not enter the body through the skin, and may be harmful.

For a complete list of videos, visit our video library